Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus

Mammalian target of rapamycin inhibitors (mTORi) are used to treat a variety of malignancies and have an established role in organ transplantation. Interstitial lung disease (ILD) is one of the complications of mTORi and is believed to be a class effect. More cases of ILD have been reported with sir...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhunaizi, Ahmed M., Al-Khouzaie, Thamer H., Alsagheir, Ahmed I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287142/
https://www.ncbi.nlm.nih.gov/pubmed/32551222
http://dx.doi.org/10.1016/j.rmcr.2020.101109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287142/
https://www.ncbi.nlm.nih.gov/pubmed/32551222
http://dx.doi.org/10.1016/j.rmcr.2020.101109

Ejemplares similares